Molecular Diagnostics Market – Global Industry Analysis and Forecast (2017 – 2026) _ by Product (Reagents & Consumables and Instruments & Systems), by Technology (Polymerase Chain Reaction (PCR), Immunochemical Technologies, and Other), by Application and by Geography

Market Scenario

Molecular Diagnostics Market is expected to reach US$ 16.7Bn by 2026 from US$ 6.8Bn in 2017 at CAGR of 11.89%. (Detailed analysis of the market CAGR is provided in the report)Molecular Diagnostics MarketMolecular Diagnostics stands for identification of a disease by studying molecules, such as proteins, DNA, and RNA, in a tissue or fluid. Molecular diagnosis is the blend of molecular biology techniques and knowledge of the molecular mechanisms of disease to diagnosis, prognostication, and treatment of diseases. This concept is a combination of laboratory medicine, genomics knowledge, and technology in the field of molecular genetics, with important discoveries in the field of molecular genomic technologies. Molecular Diagnostics is helpful in treatment of: • Infectious disease • Oncology • Human leucocytes antigen typing (which investigates and predicts immune function) • Coagulation • Pharma cogenomics According to WHO 36.7 million people were living with HIV at the end of 2017, cancer caused 8.8 million deaths in 2015, and is expected to reach 10 million by 2026. Also the number of people suffering from infectious diseases, such as gastrointestinal, respiratory, and STDs (sexually transmitted diseases) is also increasing. This will lead to raise the demand for diagnostic devices, which drives the overall molecular diagnostics market. Also, factors like increasing awareness and acceptance of personalized medicine and companion diagnostics will fuel the market growth. However, less availability of skilled labor to handle new and intricate platforms, Complex regulatory landscape due to the existence of different paths of approval and increased cost of molecular diagnostics tools will restrains the market growth. The highest revenue-generating region is North America (comprising the U.S. and Canada) followed by Europe In 2017; Due to the rising prevalence of infectious diseases, availability of government funds, expansion of the applications of molecular diagnostics in genetic disorders and cancer screening, well-penetrated healthcare system, and favorable regulatory policies.Asia Pacific is projected to be the fastest-growing region in the Molecular Diagnostics market with CAGR of 10.3% during the forecast period due to improvement in healthcare facilities to treat the increasing patient population for infectious diseases and various types of cancer. Key Highlights: • Molecular Diagnostics market analysis and forecast, in terms of volume and value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Molecular Diagnostics market. • Molecular Diagnostics market segmentation on the basis of product, technology, application and geography (country-wise) has been provided. • Molecular Diagnostics market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of the study. • Molecular Diagnostics market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Molecular Diagnostics market are also profiled. Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Molecular Diagnostics Market.  

Key Players in the Molecular Diagnostics Market Are:

• Grifols International, S.A. • Danaher Corporation • Sysmex Corporation • Siemens AG • Becton, Dickinson And Company • Biomérieux SA • Abbott • Qiagen N.V. • F. Hoffmann-La Roche Ag • Hologic Inc. Key Target Audience: • Research and Consulting Firms • molecular diagnostic instruments & assays Manufacturers and distributors • Molecular Diagnostics Market Investors • Health insurance players • Government , Healthcare Universities, Legislative and Regulatory Bodies • Molecular Diagnostics Marketing Players • Contract Research Organizations (CROS) And Contract Manufacturing Organizations (CMOS) • Traders and Stakeholders Operating In the Sector

Scope of the Molecular Diagnostics Market Report:

Research report categorizes the molecular diagnostics market based on product, application, technology, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the molecular diagnostics market with key developments in companies and market trends

Molecular Diagnostics Market, By Products

• Reagents and Consumables • Instruments and Systems

Molecular Diagnostics Market, By Technologies

• Polymerase Chain Reaction (PCR) • Immunochemical Technologies • Microarrays • Sequencing • Isothermal Nucleic Acid Amplification Technology (INAAT) • Other Technologies

Molecular Diagnostics Market, By Application

• Infectious Diseases • Oncology • Genetic Screening and Testing • Blood Screening • Microbiology • Other Applications

Molecular Diagnostics Market, By Geography:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client. Sports Medicine Market Research report

Table of Contents

Global Molecular Diagnostics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Molecular Diagnostics Market Size, by Market Value (US$ Bn ) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Molecular Diagnostics Market Analysis and Forecast 6.1. Global Molecular Diagnostics Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Molecular Diagnostics Market Analysis and Forecast, by Products 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Molecular Diagnostics Market Value Share Analysis, by Products 7.4. Global Molecular Diagnostics Market Size (US$ Bn ) Forecast, by Products 7.5. Global Molecular Diagnostics Market Analysis, by Products 7.6. Global Molecular Diagnostics Market Attractiveness Analysis, by Products 8. Global Molecular Diagnostics Market Analysis and Forecast, by Technologies 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Molecular Diagnostics Market Value Share Analysis, by Technologies 8.4. Global Molecular Diagnostics Market Size (US$ Bn ) Forecast, by Technologies 8.5. Global Molecular Diagnostics Market Analysis, by Technologies 8.6. Global Molecular Diagnostics Market Attractiveness Analysis, by Technologies 9. Global Molecular Diagnostics Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Molecular Diagnostics Market Value Share Analysis, by Application 9.4. Global Molecular Diagnostics Market Size (US$ Bn ) Forecast, by Application 9.5. Global Molecular Diagnostics Market Analysis, by Application 9.6. Global Molecular Diagnostics Market Attractiveness Analysis, by Application 10. Global Molecular Diagnostics Market Analysis, by Region 10.1. Global Molecular Diagnostics Market Value Share Analysis, by Region 10.2. Global Molecular Diagnostics Market Size (US$ Bn ) Forecast, by Region 10.3. Global Molecular Diagnostics Market Attractiveness Analysis, by Region 11. North America Molecular Diagnostics Market Analysis 11.1. Key Findings 11.2. North America Molecular Diagnostics Market Overview 11.3. North America Molecular Diagnostics Market Value Share Analysis, by Products 11.4. North America Molecular Diagnostics Market Forecast, by Products 11.4.1. Reagents and Consumables 11.4.2. Instruments and Systems 11.5. North America Molecular Diagnostics Market Value Share Analysis, by Technologies 11.6. North America Molecular Diagnostics Market Forecast, by Technologies 11.6.1. Polymerase Chain Reaction (PCR) 11.6.2. Immunochemical Technologies 11.6.3. Microarrays 11.6.4. Sequencing 11.6.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 11.6.6. Other 11.7. North America Molecular Diagnostics Market Value Share Analysis, by Application 11.8. North America Molecular Diagnostics Market Forecast, by Application 11.8.1. Infectious Diseases 11.8.2. Oncology 11.8.3. Genetic Screening and Testing 11.8.4. Blood Screening 11.8.5. Microbiology 11.8.6. Others 11.9. North America Molecular Diagnostics Market Value Share Analysis, by Country 11.10. North America Molecular Diagnostics Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Molecular Diagnostics Market Analysis, by Country 11.12. U.S. Molecular Diagnostics Market Forecast, by Products 11.12.1. Reagents and Consumables 11.12.2. Instruments and Systems 11.13. U.S. Molecular Diagnostics Market Forecast, by Technologies 11.13.1. Polymerase Chain Reaction (PCR) 11.13.2. Immunochemical Technologies 11.13.3. Microarrays 11.13.4. Sequencing 11.13.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 11.13.6. Other 11.14. U.S. Molecular Diagnostics Market Forecast, by Application 11.14.1. Infectious Diseases 11.14.2. Oncology 11.14.3. Genetic Screening and Testing 11.14.4. Blood Screening 11.14.5. Microbiology 11.14.6. Others 11.15. Canada Molecular Diagnostics Market Forecast, by Products 11.15.1. Reagents and Consumables 11.15.2. Instruments and Systems 11.16. Steel Canada Molecular Diagnostics Market Forecast, by Technologies 11.16.1. Polymerase Chain Reaction (PCR) 11.16.2. Immunochemical Technologies 11.16.3. Microarrays 11.16.4. Sequencing 11.16.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 11.16.6. Other 11.17. Canada Molecular Diagnostics Market Forecast, by Application 11.17.1. Infectious Diseases 11.17.2. Oncology 11.17.3. Genetic Screening and Testing 11.17.4. Blood Screening 11.17.5. Microbiology 11.17.6. Others 11.18. North America Molecular Diagnostics Market Attractiveness Analysis 11.18.1. By Products 11.18.2. By Technologies 11.18.3. By Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Molecular Diagnostics Market Analysis 12.1. Key Findings 12.2. Europe Molecular Diagnostics Market Overview 12.3. Europe Molecular Diagnostics Market Value Share Analysis, by Products 12.4. Europe Molecular Diagnostics Market Forecast, by Products 12.4.1. Reagents and Consumables 12.4.2. Instruments and Systems 12.5. Europe Molecular Diagnostics Market Value Share Analysis, by Technologies 12.6. Europe Molecular Diagnostics Market Forecast, by Technologies 12.6.1. Polymerase Chain Reaction (PCR) 12.6.2. Immunochemical Technologies 12.6.3. Microarrays 12.6.4. Sequencing 12.6.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.6.6. Other 12.7. Europe Molecular Diagnostics Market Value Share Analysis, by Application 12.8. Europe Molecular Diagnostics Market Forecast, by Application 12.8.1. Infectious Diseases 12.8.2. Oncology 12.8.3. Genetic Screening and Testing 12.8.4. Blood Screening 12.8.5. Microbiology 12.8.6. Others 12.9. Europe Molecular Diagnostics Market Value Share Analysis, by Country 12.10. Europe Molecular Diagnostics Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Molecular Diagnostics Market Analysis, by Country 12.12. Germany Molecular Diagnostics Market Forecast, by Products 12.12.1. Reagents and Consumables 12.12.2. Instruments and Systems 12.13. Germany Molecular Diagnostics Market Forecast, by Technologies 12.13.1. Polymerase Chain Reaction (PCR) 12.13.2. Immunochemical Technologies 12.13.3. Microarrays 12.13.4. Sequencing 12.13.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.13.6. Other 12.14. Germany Molecular Diagnostics Market Forecast, by Application 12.14.1. Infectious Diseases 12.14.2. Oncology 12.14.3. Genetic Screening and Testing 12.14.4. Blood Screening 12.14.5. Microbiology 12.14.6. Others 12.15. U.K. Molecular Diagnostics Market Forecast, by Products 12.15.1. Reagents and Consumables 12.15.2. Instruments and Systems 12.16. U.K. Molecular Diagnostics Market Forecast, by Technologies 12.16.1. Polymerase Chain Reaction (PCR) 12.16.2. Immunochemical Technologies 12.16.3. Microarrays 12.16.4. Sequencing 12.16.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.16.6. Other 12.17. U.K. Molecular Diagnostics Market Forecast, by Application 12.17.1. Infectious Diseases 12.17.2. Oncology 12.17.3. Genetic Screening and Testing 12.17.4. Blood Screening 12.17.5. Microbiology 12.17.6. Others 12.18. France Molecular Diagnostics Market Forecast, by Products 12.18.1. Reagents and Consumables 12.18.2. Instruments and Systems 12.19. France Molecular Diagnostics Market Forecast, by Technologies 12.19.1. Polymerase Chain Reaction (PCR) 12.19.2. Immunochemical Technologies 12.19.3. Microarrays 12.19.4. Sequencing 12.19.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.19.6. Other 12.20. France Molecular Diagnostics Market Forecast, by Application 12.20.1. Infectious Diseases 12.20.2. Oncology 12.20.3. Genetic Screening and Testing 12.20.4. Blood Screening 12.20.5. Microbiology 12.20.6. Others 12.21. Italy Molecular Diagnostics Market Forecast, by Products 12.21.1. Reagents and Consumables 12.21.2. Instruments and Systems 12.22. Italy Molecular Diagnostics Market Forecast, by Technologies 12.22.1. Polymerase Chain Reaction (PCR) 12.22.2. Immunochemical Technologies 12.22.3. Microarrays 12.22.4. Sequencing 12.22.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.22.6. Other 12.23. Italy Molecular Diagnostics Market Forecast, by Application 12.23.1. Infectious Diseases 12.23.2. Oncology 12.23.3. Genetic Screening and Testing 12.23.4. Blood Screening 12.23.5. Microbiology 12.23.6. Others 12.24. Spain Molecular Diagnostics Market Forecast, by Products 12.24.1. Reagents and Consumables 12.24.2. Instruments and Systems 12.25. Spain Molecular Diagnostics Market Forecast, by Technologies 12.25.1. Polymerase Chain Reaction (PCR) 12.25.2. Immunochemical Technologies 12.25.3. Microarrays 12.25.4. Sequencing 12.25.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.25.6. Other 12.26. Spain Molecular Diagnostics Market Forecast, by Application 12.26.1. Infectious Diseases 12.26.2. Oncology 12.26.3. Genetic Screening and Testing 12.26.4. Blood Screening 12.26.5. Microbiology 12.26.6. Others 12.27. Rest of Europe Molecular Diagnostics Market Forecast, by Products 12.27.1. Reagents and Consumables 12.27.2. Instruments and Systems 12.28. Rest of Europe Molecular Diagnostics Market Forecast, by Technologies 12.28.1. Polymerase Chain Reaction (PCR) 12.28.2. Immunochemical Technologies 12.28.3. Microarrays 12.28.4. Sequencing 12.28.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.28.6. Other 12.29. Rest Of Europe Molecular Diagnostics Market Forecast, by Application 12.29.1. Infectious Diseases 12.29.2. Oncology 12.29.3. Genetic Screening and Testing 12.29.4. Blood Screening 12.29.5. Microbiology 12.29.6. Others 12.30. Europe Molecular Diagnostics Market Attractiveness Analysis 12.30.1. By Products 12.30.2. By Technologies 12.30.3. By Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Molecular Diagnostics Market Analysis 13.1. Key Findings 13.2. Asia Pacific Molecular Diagnostics Market Overview 13.3. Asia Pacific Molecular Diagnostics Market Value Share Analysis, by Products 13.4. Asia Pacific Molecular Diagnostics Market Forecast, by Products 13.4.1. Reagents and Consumables 13.4.2. Instruments and Systems 13.5. Asia Pacific Molecular Diagnostics Market Value Share Analysis, by Technologies 13.6. Asia Pacific Molecular Diagnostics Market Forecast, by Technologies 13.6.1. Polymerase Chain Reaction (PCR) 13.6.2. Immunochemical Technologies 13.6.3. Microarrays 13.6.4. Sequencing 13.6.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.6.6. Other 13.7. Asia Pacific Molecular Diagnostics Market Value Share Analysis, by Application 13.8. Asia Pacific Molecular Diagnostics Market Forecast, by Application 13.8.1. Infectious Diseases 13.8.2. Oncology 13.8.3. Genetic Screening and Testing 13.8.4. Blood Screening 13.8.5. Microbiology 13.8.6. Others 13.9. Asia Pacific Molecular Diagnostics Market Value Share Analysis, by Country 13.10. Asia Pacific Molecular Diagnostics Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Molecular Diagnostics Market Analysis, by Country 13.12. China Molecular Diagnostics Market Forecast, by Products 13.12.1. Reagents and Consumables 13.12.2. Instruments and Systems 13.13. China Molecular Diagnostics Market Forecast, by Technologies 13.13.1. Polymerase Chain Reaction (PCR) 13.13.2. Immunochemical Technologies 13.13.3. Microarrays 13.13.4. Sequencing 13.13.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.13.6. Other 13.14. China Molecular Diagnostics Market Forecast, by Application 13.14.1. Infectious Diseases 13.14.2. Oncology 13.14.3. Genetic Screening and Testing 13.14.4. Blood Screening 13.14.5. Microbiology 13.14.6. Others 13.15. India Molecular Diagnostics Market Forecast, by Products 13.15.1. Reagents and Consumables 13.15.2. Instruments and Systems 13.16. India Molecular Diagnostics Market Forecast, by Technologies 13.16.1. Polymerase Chain Reaction (PCR) 13.16.2. Immunochemical Technologies 13.16.3. Microarrays 13.16.4. Sequencing 13.16.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.16.6. Other 13.17. India Molecular Diagnostics Market Forecast, by Application 13.17.1. Infectious Diseases 13.17.2. Oncology 13.17.3. Genetic Screening and Testing 13.17.4. Blood Screening 13.17.5. Microbiology 13.17.6. Others 13.18. Japan Molecular Diagnostics Market Forecast, by Products 13.18.1. Reagents and Consumables 13.18.2. Instruments and Systems 13.19. Japan Molecular Diagnostics Market Forecast, by Technologies 13.19.1. Polymerase Chain Reaction (PCR) 13.19.2. Immunochemical Technologies 13.19.3. Microarrays 13.19.4. Sequencing 13.19.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.19.6. Other 13.20. Japan Molecular Diagnostics Market Forecast, by Application 13.20.1. Infectious Diseases 13.20.2. Oncology 13.20.3. Genetic Screening and Testing 13.20.4. Blood Screening 13.20.5. Microbiology 13.20.6. Others 13.21. ASEAN Molecular Diagnostics Market Forecast, by Products 13.21.1. Reagents and Consumables 13.21.2. Instruments and Systems 13.22. ASEAN Molecular Diagnostics Market Forecast, by Technologies 13.22.1. Polymerase Chain Reaction (PCR) 13.22.2. Immunochemical Technologies 13.22.3. Microarrays 13.22.4. Sequencing 13.22.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.22.6. Other 13.23. ASEAN Molecular Diagnostics Market Forecast, by Application 13.23.1. Infectious Diseases 13.23.2. Oncology 13.23.3. Genetic Screening and Testing 13.23.4. Blood Screening 13.23.5. Microbiology 13.23.6. Others 13.24. Rest of Asia Pacific Molecular Diagnostics Market Forecast, by Products 13.24.1. Reagents and Consumables 13.24.2. Instruments and Systems 13.25. Rest of Asia Pacific Molecular Diagnostics Market Forecast, by Technologies 13.25.1. Polymerase Chain Reaction (PCR) 13.25.2. Immunochemical Technologies 13.25.3. Microarrays 13.25.4. Sequencing 13.25.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.25.6. Other 13.26. Rest of Asia Pacific Molecular Diagnostics Market Forecast, by Application 13.26.1. Infectious Diseases 13.26.2. Oncology 13.26.3. Genetic Screening and Testing 13.26.4. Blood Screening 13.26.5. Microbiology 13.26.6. Others 13.27. Asia Pacific Molecular Diagnostics Market Attractiveness Analysis 13.27.1. By Products 13.27.2. By Technologies 13.27.3. By Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Molecular Diagnostics Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Molecular Diagnostics Market Overview 14.3. Middle East & Africa Molecular Diagnostics Market Value Share Analysis, by Products 14.4. Middle East & Africa Molecular Diagnostics Market Forecast, by Products 14.4.1. Reagents and Consumables 14.4.2. Instruments and Systems 14.5. Middle East & Africa Molecular Diagnostics Market Value Share Analysis, by Technologies 14.6. Middle East & Africa Molecular Diagnostics Market Forecast, by Technologies 14.6.1. Polymerase Chain Reaction (PCR) 14.6.2. Immunochemical Technologies 14.6.3. Microarrays 14.6.4. Sequencing 14.6.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.6.6. Other 14.7. Middle East & Africa Molecular Diagnostics Market Value Share Analysis, by Application 14.8. Middle East & Africa Molecular Diagnostics Market Forecast, by Application 14.8.1. Infectious Diseases 14.8.2. Oncology 14.8.3. Genetic Screening and Testing 14.8.4. Blood Screening 14.8.5. Microbiology 14.8.6. Others 14.9. Middle East & Africa Molecular Diagnostics Market Value Share Analysis, by Country 14.10. Middle East & Africa Molecular Diagnostics Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Molecular Diagnostics Market Analysis, by Country 14.12. GCC Molecular Diagnostics Market Forecast, by Products 14.12.1. Reagents and Consumables 14.12.2. Instruments and Systems 14.13. GCC Molecular Diagnostics Market Forecast, by Technologies 14.13.1. Polymerase Chain Reaction (PCR) 14.13.2. Immunochemical Technologies 14.13.3. Microarrays 14.13.4. Sequencing 14.13.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.13.6. Other 14.14. GCC Molecular Diagnostics Market Forecast, by Application 14.14.1. Infectious Diseases 14.14.2. Oncology 14.14.3. Genetic Screening and Testing 14.14.4. Blood Screening 14.14.5. Microbiology 14.14.6. Others 14.15. South Africa Molecular Diagnostics Market Forecast, by Products 14.15.1. Reagents and Consumables 14.15.2. Instruments and Systems 14.16. South Africa Molecular Diagnostics Market Forecast, by Technologies 14.16.1. Polymerase Chain Reaction (PCR) 14.16.2. Immunochemical Technologies 14.16.3. Microarrays 14.16.4. Sequencing 14.16.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.16.6. Other 14.17. South Africa Molecular Diagnostics Market Forecast, by Application 14.17.1. Infectious Diseases 14.17.2. Oncology 14.17.3. Genetic Screening and Testing 14.17.4. Blood Screening 14.17.5. Microbiology 14.17.6. Others 14.18. Rest of Middle East & Africa Molecular Diagnostics Market Forecast, by Products 14.18.1. Reagents and Consumables 14.18.2. Instruments and Systems 14.19. Rest of Middle East & Africa Molecular Diagnostics Market Forecast, by Technologies 14.19.1. Polymerase Chain Reaction (PCR) 14.19.2. Immunochemical Technologies 14.19.3. Microarrays 14.19.4. Sequencing 14.19.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.19.6. Other 14.20. Rest of Middle East & Africa Molecular Diagnostics Market Forecast, by Application 14.20.1. Infectious Diseases 14.20.2. Oncology 14.20.3. Genetic Screening and Testing 14.20.4. Blood Screening 14.20.5. Microbiology 14.20.6. Others 14.21. Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis 14.21.1. By Products 14.21.2. By Technologies 14.21.3. By Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Molecular Diagnostics Market Analysis 15.1. Key Findings 15.2. South America Molecular Diagnostics Market Overview 15.3. South America Molecular Diagnostics Market Value Share Analysis, by Products 15.4. South America Molecular Diagnostics Market Forecast, by Products 15.4.1. Reagents and Consumables 15.4.2. Instruments and Systems 15.5. South America Molecular Diagnostics Market Value Share Analysis, by Technologies 15.6. South America Molecular Diagnostics Market Forecast, by Technologies 15.6.1. Polymerase Chain Reaction (PCR) 15.6.2. Immunochemical Technologies 15.6.3. Microarrays 15.6.4. Sequencing 15.6.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.6.6. Other 15.7. South America Molecular Diagnostics Market Value Share Analysis, by Application 15.8. South America Molecular Diagnostics Market Forecast, by Application 15.8.1. Infectious Diseases 15.8.2. Oncology 15.8.3. Genetic Screening and Testing 15.8.4. Blood Screening 15.8.5. Microbiology 15.8.6. Others 15.9. South America Molecular Diagnostics Market Value Share Analysis, by Country 15.10. South America Molecular Diagnostics Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Molecular Diagnostics Market Analysis, by Country 15.12. Brazil Molecular Diagnostics Market Forecast, by Products 15.12.1. Reagents and Consumables 15.12.2. Instruments and Systems 15.13. Brazil Molecular Diagnostics Market Forecast, by Technologies 15.13.1. Polymerase Chain Reaction (PCR) 15.13.2. Immunochemical Technologies 15.13.3. Microarrays 15.13.4. Sequencing 15.13.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.13.6. Other 15.14. Brazil Molecular Diagnostics Market Forecast, by Application 15.14.1. Infectious Diseases 15.14.2. Oncology 15.14.3. Genetic Screening and Testing 15.14.4. Blood Screening 15.14.5. Microbiology 15.14.6. Others 15.15. Mexico Molecular Diagnostics Market Forecast, by Products 15.15.1. Reagents and Consumables 15.15.2. Instruments and Systems 15.16. Mexico Molecular Diagnostics Market Forecast, by Technologies 15.16.1. Polymerase Chain Reaction (PCR) 15.16.2. Immunochemical Technologies 15.16.3. Microarrays 15.16.4. Sequencing 15.16.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.16.6. Other 15.17. Mexico Molecular Diagnostics Market Forecast, by Application 15.17.1. Infectious Diseases 15.17.2. Oncology 15.17.3. Genetic Screening and Testing 15.17.4. Blood Screening 15.17.5. Microbiology 15.17.6. Others 15.18. Rest of South America Molecular Diagnostics Market Forecast, by Products 15.18.1. Reagents and Consumables 15.18.2. Instruments and Systems 15.19. Rest of South America Molecular Diagnostics Market Forecast, by Technologies 15.19.1. Polymerase Chain Reaction (PCR) 15.19.2. Immunochemical Technologies 15.19.3. Microarrays 15.19.4. Sequencing 15.19.5. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.19.6. Other 15.20. Rest of South America Molecular Diagnostics Market Forecast, by Application 15.20.1. Infectious Diseases 15.20.2. Oncology 15.20.3. Genetic Screening and Testing 15.20.4. Blood Screening 15.20.5. Microbiology 15.20.6. Others 15.21. South America Molecular Diagnostics Market Attractiveness Analysis 15.21.1. By Products 15.21.2. By Technologies 15.21.3. By Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Grifols International, S.A. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Manufacturing Footprint 16.3.2. Danaher Corporation 16.3.3. Sysmex Corporation 16.3.4. Siemens AG 16.3.5. Becton, Dickinson And Company 16.3.6. Biomérieux SA 16.3.7. Abbott 16.3.8. Qiagen N.V. 16.3.9. F. Hoffmann-La Roche Ag 16.3.10. Hologic Inc. 17. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID610
Category Healthcare
Publisher Name
No of Pages
Total Views
Published DateDec 2017
Contact Us
Call Now